Anavex Life Sciences Corp (NASDAQ:AVXL)
| 18.74 Delayed Data As of Sep 24 |  -0.55 / -2.85%Today’s Change | 3.82 Today|||52-Week Range 31.50 | +246.94% Year-to-Date |
Largest transactions by value over
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Favus Elliot Jay Director |  Sale | 2/24/2021 | 145,500 | $12.66 | $1.8M | +51.62% |
Favus Elliot Jay Director | Sale | 5/21/2021 | 145,000 | $11.70 | $1.7M | +60.45% |
Favus Elliot Jay Director |  Buy | 2/24/2021 | 100,000 | $3.28 | $328.0K | +51.62% |
Favus Elliot Jay Director | Buy | 5/21/2021 | 50,000 | $2.96 | $148.0K | +60.45% |
Favus Elliot Jay Director | Buy | 2/24/2021 | 45,500 | $2.58 | $117.4K | +51.62% |
Favus Elliot Jay Director | Buy | 5/21/2021 | 50,000 | $0.92 | $46.0K | +60.45% |
Favus Elliot Jay Director | Buy | 5/21/2021 | 37,500 | $1.20 | $45.0K | +60.45% |
Donhauser Peter Director | Buy | 2/19/2021 | 1,000 | $12.62 | $12.6K | +49.44% |
Donhauser Peter Director | Buy | 5/17/2021 | 1,000 | $10.93 | $10.9K | +66.13% |
Favus Elliot Jay Director | Buy | 5/21/2021 | 1,500 | $6.11 | $9.2K | +60.45% |
Page of 2